MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 250 filers reported holding MEDIVATION INC in Q2 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $120,684,000 | +423.9% | 2,001,400 | +299.5% | 1.26% | +420.2% |
| Q1 2016 | $23,036,000 | +192.4% | 501,000 | +207.4% | 0.24% | +240.8% |
| Q4 2015 | $7,879,000 | -95.1% | 163,000 | -88.5% | 0.07% | -94.0% |
| Q2 2015 | $161,410,000 | -46.8% | 1,413,400 | -39.8% | 1.18% | -54.3% |
| Q1 2015 | $303,173,000 | +34.1% | 2,348,900 | +3.5% | 2.59% | +19.8% |
| Q4 2014 | $226,005,000 | +0.6% | 2,268,900 | -0.2% | 2.16% | -8.0% |
| Q3 2014 | $224,732,000 | +19.2% | 2,273,000 | -7.1% | 2.35% | +6.0% |
| Q2 2014 | $188,584,000 | +7.5% | 2,446,600 | -10.2% | 2.21% | +2.7% |
| Q1 2014 | $175,350,000 | -12.0% | 2,724,100 | -12.8% | 2.16% | -26.4% |
| Q4 2013 | $199,342,000 | +42.5% | 3,123,500 | +33.8% | 2.93% | +17.3% |
| Q3 2013 | $139,930,000 | +93.2% | 2,334,500 | +58.6% | 2.50% | +62.7% |
| Q2 2013 | $72,427,000 | – | 1,472,100 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |